Any bid would compete against a $13.25-per-share proposal made by R1’s largest investor, New Mountain Capital, according to the report.
New Mountain and TCP-ASC — an investment vehicle jointly owned by TowerBrook and Ascension Health Alliance — previously discussed a joint proposal to take R1 private but were unable to come to an agreement, according to the report. New Mountain, which has a 32% interest in the company, decided to go solo on its offer.
Deliberations between TowerBrook and CD&R are ongoing and there is no certainty they will proceed with a bid, sources who asked not to be identified discussing confidential information told Bloomberg.
TowerBrook is R1’s second-largest shareholder with about a 30% stake in the company, according to the report.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.